Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
about
Short and long term effects of tibolone in postmenopausal womenTibolone: the way to beat many a postmenopausal ailmentsLow-dose hormone replacement therapy: effects on bone.Novel therapies for osteoporosis.Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety.Tibolone: a unique version of hormone replacement therapy.A review of the effects of tibolone on the skeleton.Application of a Systems Pharmacology-Based Placebo Population Model to Analyze Long-Term Data of Postmenopausal Osteoporosis.Hormone replacement therapy and the prevention of postmenopausal osteoporosis.Emerging and potential therapies for osteoporosis.The effects of tibolone in older postmenopausal women.Emerging pharmacologic therapies for osteoporosis.A Comparative Study of CEE, Tibolone, and DHEA as Hormone Replacement Therapy for Surgical Menopause.Tibolone rapidly attenuates the GABAB response in hypothalamic neurones.Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.Sex hormones and lipoprotein(a) concentration.Short-term and long-term effects of tibolone in postmenopausal women.Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke.Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.A longitudinal evaluation of the effect of two doses of tibolone on bone density and metabolism in early postmenopausal women.The influence of 5-year therapy with tibolone on the lipid profile in postmenopausal women with mild hypercholesterolemia.Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.Selective estrogen receptor modulator promotes weight loss in ovariectomized female rhesus monkeys (Macaca mulatta) by decreasing food intake and increasing activity.Historical milestones in the development of tibolone (Livial®).
P2860
Q24203695-DC56D756-470D-4A2D-80F0-9C74843FBE7EQ28274518-DC3D6594-0DBE-485F-A9FE-DFFEA3647A1FQ34672074-690694E5-D88D-4A7D-93A2-B167F96CFC60Q35094675-616124D3-D23A-4AC9-A0DF-E9DCC9027C77Q35194552-DE00E9FA-EDC1-452D-BE36-72FF5E6B1DC0Q35693770-A411589C-7F5C-4BA9-BBF5-597D7D3DDCC1Q35753441-6BE6B6E8-FC11-4738-B77D-1B785A37725FQ35801353-5B74E33F-D255-4C45-89A6-F94A6EB5EE62Q35903603-BF5FC12E-EE19-47BF-86F9-16B92C1B1402Q36099415-3FD48A23-52E5-414D-A848-6C2EC36F0C82Q36933363-A9F1DBB0-B5BB-446F-A7BB-79337C40651EQ36944034-B611031E-A299-4776-8876-FAFDECAD0F00Q36965277-69241AEA-9253-4819-A7A3-0FE09D57BB0EQ37037228-3888BA24-9788-469E-A48B-22BF9606802EQ37768413-F1748D54-2B5A-469A-8FF3-078F0F239C69Q37825893-DAF6A6BE-60CD-4566-9936-4401EC359BAEQ38979006-D8C37326-4780-4F54-9964-AAB6B2855E22Q43227535-BC1C1B59-5632-4565-A186-D64CA1DEB358Q44355123-2AC09E1B-CF59-4E7A-B15D-AC58D13BA5D4Q44857803-B469F629-8D4B-4746-8D9F-BCC13A4610BDQ45007010-1D71BEFD-44A4-4AA5-A273-F93EAF19F029Q46877651-887A7F2E-44C7-4D38-8BF6-8DAB52BB5F73Q47331580-155FDB69-9192-4469-8881-E2433B13F7DBQ48586031-ACB5202D-6A2D-4A77-9702-308F0B72F75A
P2860
Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Prevention of bone loss with t ...... trolled, dose-finding studies.
@en
Prevention of bone loss with t ...... trolled, dose-finding studies.
@nl
type
label
Prevention of bone loss with t ...... trolled, dose-finding studies.
@en
Prevention of bone loss with t ...... trolled, dose-finding studies.
@nl
prefLabel
Prevention of bone loss with t ...... trolled, dose-finding studies.
@en
Prevention of bone loss with t ...... trolled, dose-finding studies.
@nl
P2093
P356
P1476
Prevention of bone loss with t ...... trolled, dose-finding studies.
@en
P2093
Baylink DJ
Gallagher JC
P304
P356
10.1210/JCEM.86.10.7937
P407
P577
2001-10-01T00:00:00Z